Two different fibrinogen gene mutations associated with bleeding in the same family (AαGly13Glu and γGly16Ser) and their impact on fibrin clot properties: Fibrinogen Krakow II and Krakow III

• References

• 1 Roberts HR, Stinchcombe TE, Gabriel DA. The dysfibrinogenaemias. Br J Haematol 2001; 114: 249-257.
• 2 Neerman-Arbez M, de Moerloose P. Mutations in the fibrinogen gene cluster accounting for congenital afibrinogenemia: an update and report of ten novel mutations. Hum Mut 2007; 28: 540-553.
• 3 Neerman-Arbez M, de Moerloose P, Honsberger A. et al. Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes. Hum Genet 2001; 108: 237-240.
• 4 Kotlin R, Zichova K, Suttnar J. et al. Congenital dysfibrinogenemia Aα Gly13Glu associated with bleeding during pregnancy. Thromb Res 2011; 127: 277-278.
• 5 Undas A, Zawilska K, Ciesla-Dul M. et al. Altered fibrin clot structure/function in patients with idiopathic venous thrombembolism and in their relatives. Blood 2009; 114: 4272-4278.
• 6 Undas A, Pastuszczak M, Iwaniec T. et al. Functional characterisation of plasma fibrin clots in Polish carriers of fibrinogen gammaArg275His mutation (fibrinogen Zabrze). Thromb Haemost 2010; 104: 415-417.
• 7 Undas A, Zdziarska J, Basa J. et al. Fibrinogen Krakow: a novel hypodysfibrinogenemia mutation in FGG (Asn325Ile) affecting fibrin structure and function. Thromb Haemost 2009; 101: 975-976.
• 8 Neerman Arbez M, de Moerloose P. Hereditary fibrinogen abnormalities. Williams’ Hematology. 8^th Ed McGraw-Hill; New York: 2010: 2051-2068
• 9 Scott EM, Ariëns RAS, Grant PJ. Genetic and environmental determinants of fibrin structure and function. Relevance to clinical disease. Arterioscler Thromb Vasc Biol 2004; 24: 1558-1566.